{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:32:09Z","timestamp":1792571529294,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T00:00:00Z","timestamp":1374192000000},"content-version":"vor","delay-in-days":2087,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Human Genetics"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1086\/521032","type":"journal-article","created":{"date-parts":[[2007,10,19]],"date-time":"2007-10-19T12:25:28Z","timestamp":1192796728000},"page":"873-883","source":"Crossref","is-referenced-by-count":403,"title":["A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer\u2013Predisposition Genes"],"prefix":"10.1016","volume":"81","author":[{"given":"Douglas F.","family":"Easton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie M.","family":"Deffenbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Pruss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Wenstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Allen-Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean V.","family":"Tavtigian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro N.A.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin S.","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus J.","family":"Couch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Goldgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1086\/521032_bib4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.1997.03540360065034","article-title":"Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2\u2014Cancer Genetics Studies Consortium","volume":"277","author":"Burke","year":"1997","journal-title":"JAMA"},{"key":"10.1086\/521032_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3233\/CBM-2006-21-203","article-title":"The use of microsatellite instability, immunohistochemistry and other variables in determining the clinical significance of MLH1 and MSH2 unclassified variants in Lynch syndrome","volume":"2","author":"Lucci-Cordisco","year":"2006","journal-title":"Cancer Biomark"},{"key":"10.1086\/521032_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/424388","article-title":"Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2","volume":"75","author":"Goldgar","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1086\/521032_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4161\/cbt.3.5.831","article-title":"Methods to classify BRCA1 variants of uncertain clinical significance: the more the merrier","volume":"3","author":"Billack","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"10.1086\/521032_bib8","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1158\/0008-5472.CAN-05-3034","article-title":"Cancer risk assessment at the atomic level","volume":"66","author":"Monteiro","year":"2006","journal-title":"Cancer Res"},{"key":"10.1086\/521032_bib9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1086\/378100","article-title":"A full-likelihood method for the evaluation of causality of sequence variants from family data","volume":"73","author":"Thompson","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1086\/521032_bib10","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1086\/301871","article-title":"Missense mutations in disease genes: a Bayesian approach to evaluate causality","volume":"62","author":"Petersen","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1086\/521032_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1198\/016214504000001817","article-title":"Classification of missense mutations of disease genes","volume":"100","author":"Zhou","year":"2005","journal-title":"J Am Stat Assn"},{"key":"10.1086\/521032_bib12","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1158\/0008-5472.CAN-05-1241","article-title":"Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations","volume":"65","author":"Judkins","year":"2005","journal-title":"Cancer Res"},{"key":"10.1086\/521032_bib13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jmg.2003.015867","article-title":"Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation","volume":"41","author":"Abkevich","year":"2004","journal-title":"J Med Genet"},{"key":"10.1086\/521032_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10689-005-2578-0","article-title":"An analysis of unclassified missense substitutions in human BRCA1","volume":"5","author":"Tavtigian","year":"2006","journal-title":"Fam Cancer"},{"key":"10.1086\/521032_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jmg.2005.033878","article-title":"Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral","volume":"43","author":"Tavtigian","year":"2006","journal-title":"J Med Genet"},{"key":"10.1086\/521032_bib16","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/hmg\/10.21.2319","article-title":"Understanding human disease mutations through the use of interspecific genetic variation","volume":"10","author":"Miller","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1086\/521032_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/hmg\/10.6.591","article-title":"Prediction of deleterious human alleles","volume":"10","author":"Sunyaev","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1086\/521032_bib18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.185.4154.862","article-title":"Amino acid difference formula to help explain protein evolution","volume":"185","author":"Grantham","year":"1974","journal-title":"Science"},{"key":"10.1086\/521032_bib19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/382678a0","article-title":"Transcriptional activation by BRCA1","volume":"382","author":"Chapman","year":"1996","journal-title":"Nature"},{"key":"10.1086\/521032_bib20","doi-asserted-by":"crossref","first-page":"13595","DOI":"10.1073\/pnas.93.24.13595","article-title":"Evidence for a transcriptional activation function of BRCA1 C-terminal region","volume":"93","author":"Monteiro","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1086\/521032_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cancergencyto.2004.01.020","article-title":"The effects of BRCA1 missense variants V1804D and M1628T on transcriptional activity","volume":"153","author":"Ostrow","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1086\/521032_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jmg.2004.024711","article-title":"Classification of BRCA1 missense variants of unknown clinical significance","volume":"42","author":"Phelan","year":"2005","journal-title":"J Med Genet"},{"key":"10.1086\/521032_bib23","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1158\/0008-5472.CAN-06-3297","article-title":"Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis","volume":"67","author":"Carvalho","year":"2007","journal-title":"Cancer Res"},{"key":"10.1086\/521032_bib24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/hmg\/ddi476","article-title":"Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility","volume":"15","author":"Morris","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1086\/521032_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1158\/0008-5472.417.65.2","article-title":"Functional evaluation and cancer risk assessment of BRCA2 unclassified variants","volume":"65","author":"Wu","year":"2005","journal-title":"Cancer Res"},{"key":"10.1086\/521032_bib26","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1158\/0008-5472.CAN-03-3009","article-title":"Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition","volume":"64","author":"Mirkovic","year":"2004","journal-title":"Cancer Res"},{"key":"10.1086\/521032_bib27","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1371\/journal.pcbi.0030026","article-title":"Functional impact of missense variants in BRCA1 predicted by supervised learning","volume":"3","author":"Karchin","year":"2007","journal-title":"PLoS Comput Biol"},{"key":"10.1086\/521032_bib28","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.297.5588.1837","article-title":"BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure","volume":"297","author":"Yang","year":"2002","journal-title":"Science"},{"key":"10.1086\/521032_bib29","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1038\/sj.onc.1204363","article-title":"A targeted mouse BRCA1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage","volume":"20","author":"Hohenstein","year":"2001","journal-title":"Oncogene"},{"key":"10.1086\/521032_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ng0296-191","article-title":"Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities","volume":"12","author":"Gowen","year":"1996","journal-title":"Nat Genet"},{"key":"10.1086\/521032_bib31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.1073834","article-title":"Biallelic inactivation of BRCA2 in Fanconi anemia","volume":"297","author":"Howlett","year":"2002","journal-title":"Science"},{"key":"10.1086\/521032_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2006.043257","article-title":"Clinical and molecular features associated with biallelic mutations in FANCD1\/BRCA2","volume":"44","author":"Alter","year":"2007","journal-title":"J Med Genet"},{"key":"10.1086\/521032_bib33","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1086\/521032_bib34","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1073\/pnas.81.11.3443","article-title":"Strategies for multilocus linkage analysis in humans","volume":"81","author":"Lathrop","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1086\/521032_bib35","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","article-title":"The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2","volume":"20","author":"Lakhani","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1086\/521032_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/ng1092-128","article-title":"Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome","volume":"2","author":"Smith","year":"1992","journal-title":"Nat Genet"},{"key":"10.1086\/521032_bib37","first-page":"1673","article-title":"Consistent loss of the wild-type allele in breast cancers from a family linked to the Brca2 gene on chromosome 13q12-13","volume":"10","author":"Collins","year":"1995","journal-title":"Oncogene"},{"key":"10.1086\/521032_bib38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/humu.20470","article-title":"Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information","volume":"28","author":"Osorio","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1086\/521032_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jmg.2005.033258","article-title":"Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants","volume":"43","author":"Lovelock","year":"2006","journal-title":"J Med Genet"},{"key":"10.1086\/521032_bib40","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1158\/0008-5472.CAN-05-3546","article-title":"Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance","volume":"66","author":"Chenevix-Trench","year":"2006","journal-title":"Cancer Res"}],"container-title":["The American Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929707638658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929707638658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T12:51:09Z","timestamp":1684068669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002929707638658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0002929707638658"],"URL":"https:\/\/doi.org\/10.1086\/521032","relation":{},"ISSN":["0002-9297"],"issn-type":[{"value":"0002-9297","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}